pharmindo.com
PHarmIndo.com is available at DomainMarket.comJoin thousands of profitable companies that generate business through a premium domain that is easy to remember and helps with your search rankings.
http://www.pharmindo.com/
Join thousands of profitable companies that generate business through a premium domain that is easy to remember and helps with your search rankings.
http://www.pharmindo.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
2.1 seconds
16x16
32x32
DOMAIN ASSET HOLDINGS, LLC
DOMAIN ADMINISTRATOR
9812 FALLS●●●●●●●●●●TE 114-331
PO●●AC , MD, 8402020854
US
View this contact
DOMAIN ASSET HOLDINGS, LLC
DOMAIN ADMINISTRATOR
9812 FALLS●●●●●●●●●●TE 114-331
PO●●AC , MD, 8402020854
US
View this contact
DOMAIN ASSET HOLDINGS, LLC
DOMAIN ADMINISTRATOR
9812 FALLS●●●●●●●●●●TE 114-331
PO●●AC , MD, 8402020854
US
View this contact
11
YEARS
11
MONTHS
24
DAYS
ENOM, INC.
WHOIS : whois.enom.com
REFERRED : http://www.enom.com
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
0
SITE IP
173.239.23.228
LOAD TIME
2.125 sec
SCORE
6.2
PHarmIndo.com is available at DomainMarket.com | pharmindo.com Reviews
https://pharmindo.com
Join thousands of profitable companies that generate business through a premium domain that is easy to remember and helps with your search rankings.
PHARMINDEX termékek és szolgáltatások | PHARMINDEX
Nincsenek termékek a kosárban. PHARMINDEX termékek és szolgáltatások. Ismerje meg a PHARMINDEX termékeket és szolgáltatásokat! Rendelje meg egyszerűen és gyorsan, amire munkájához szüksége van! A félévente megjelenő PHARMINDEX Zsebkönyv. Magyarországon az EGYETLEN, rendszeresen megjelenő, nyomtatott formában elérhető gyógyszer-információs kiadvány. Nélkülözhetetlen segítőtárs a terápiás döntésben és a napi receptfelírás során. PHARMINDEX adatokon alapuló gyógyszer-információs tudástár. Android.
PHARMINDEX - Regisztráció
Az ezen az oldalon történő regisztrációjával Ön jogosulttá válik a PHARMINDEX.hu kiadványajánló oldal. Használatára, ahol az Vidal Hungary Kft. Által megjelentetett elektronikus és nyomtatott kiadványai közül rendelhet. Amennyiben a későbbiekben hozzáférést kíván kapni a Medimagister.hu egészségügyi szakmai továbbképző oldalunkhoz. Illetve a PHARMINDEX-Online.hu gyógyszer-információs adatbázishoz. Kérjük, hogy látogasson el az oldalakra és egészítse ki regisztrációját.
Pharmindex
Aby znaleźć lek, uzupełnij lub wybierz przynamniej jedno pole. Zakres wskazań objętych refundacją:. Wskazania pozarejestracyjne objęte refundacją:. PHARMINDEX Poland Sp. z o.o. 48 801 196 449. Korzystając z serwisu Pharmindex wyrażasz zgodę na używanie ciasteczek (cookies). Możesz zmienić ustawienia dotyczące cookies w Twojej przeglądarce.
ФАРМ-индекс webcard n2506 стр.0
Автоматизированная система ведения титульной информации об участниках рынка интеллектуальных компьютерных технологий,. И не только . Кнопка на страницу фирмы в ежемесячной энциклопедии. Телефон можно уточнить у администратора домена. 125190, Москва, а/я 238. Свидетельство о регистрации периодического издания. N 215 от 19.09.1990. ООО Редакция журнала Персональные Программы. Personal Software Magazine WebCard. Обновления и архивы: http:/ pharmindex.ps1.su. Http:/ pharmindex.p-pp.ru. Если Вы одобряете наш ...
ФАРМ-индекс - справочная, поиск лекарств и цены в аптеках
ФАРМ-индекс - справочная аптек Москвы, Санкт-Петербурга и городов России, цены в аптеках. Поиск лекарств по алфавиту. БАД и лечебное питание. Газета «Аптека». Сайт является исключительно информационным и не является публичной офертой, определяемой положением статьи 437-2 гражданского кодекса РФ. Сайт не занимается продажей или доставкой товаров, информация о которых размещена на его страницах. Информационно-издательский центр «ФАРМиндекс». Справочная аптек Москвы, Санкт-Петербурга и городов России.
PHarmIndo.com is available at DomainMarket.com
Ask About Special April Deals! What Are the Advantages of a Super Premium .Com Domain? 1 in Premium Domains. 300,000 of the World's Best .Com Domains. Available For Immediate Purchase. Safe and Secure Transactions. 24/7 Customer Support: 888-694-6735. Search For a Premium Domain. Or Click Here To Get Your Own Domains Appraised. Find more domains similar to PHarmIndo.com. We are constantly expanding our inventory to give you the best domains available for purchase! Domains Added in the Past Month. That wo...
Pharmaceutical Industry
Wednesday, April 06, 2005. Large Profits are a Significant Source of Criticism of the Biopharmaceutical industry. All Kriger career training modules ( www.krctraining.com. Politicians, consumer groups, physicians’ organizations, academic journals, and the mass media have all been vocal in their criticism of drug pricing. The pharmaceutical industry is an easy target for these critics, being both highly visible and financially successful. True costs of R&D expense. Posted by Clinical Research Career at 9:...
pharmindustry.com - This website is for sale! - pharm industry Resources and Information.
The domain pharmindustry.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
Pharmine
We are pleased to announce that the PHARMINE project has been funded with support from the European Commission, Lifelong Learning Programme of the European Union:. Final Report – Lisbon June 2011.
Pharminent
Subscribe to email list. Subscribe to email list. February 1, 2018. February 11, 2018. Biogen looking to up its stake in Samsung biosimilar JV. Biogen has reported record biosimilar revenues and says it intends to increase its share in Samsung Bioepis. https:/ www.biopharma-reporter.com/Article/2018/01/26/Biogen-looking-to-up-its-stake-in-Samsung-biosimilar-JV. January 31, 2018. February 11, 2018. Boehringer strikes Jardiance outcomes deal with Prime PBM. January 26, 2018. February 11, 2018. The post Nov...
Pharma Industry News - Updated Daily
Directory of Pharma Companies and News. Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with secondary progress. CV Sciences, Inc. to Host Fourth Quarter and Year End 2017 Financial Results Conference Call on Thursday, March 29, 2018. Updated TACTI-mel Data Presented at the Cambridge Healthtech Institute’s Immuno-Oncology Summit. Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with secondary progress.
SOCIAL ENGAGEMENT